196 related articles for article (PubMed ID: 27305832)
1. Nanoparticle formulation of 11-keto-β-boswellic acid (KBA): anti-inflammatory activity and in vivo pharmacokinetics.
Bairwa K; Jachak SM
Pharm Biol; 2016 Dec; 54(12):2909-2916. PubMed ID: 27305832
[TBL] [Abstract][Full Text] [Related]
2. Development and optimisation of 3-Acetyl-11-keto-β-boswellic acid loaded poly-lactic-co-glycolic acid-nanoparticles with enhanced oral bioavailability and in-vivo anti-inflammatory activity in rats.
Bairwa K; Jachak SM
J Pharm Pharmacol; 2015 Sep; 67(9):1188-97. PubMed ID: 25851251
[TBL] [Abstract][Full Text] [Related]
3. Enhanced absorption of boswellic acids by a lecithin delivery form (Phytosome(®)) of Boswellia extract.
Hüsch J; Bohnet J; Fricker G; Skarke C; Artaria C; Appendino G; Schubert-Zsilavecz M; Abdel-Tawab M
Fitoterapia; 2013 Jan; 84():89-98. PubMed ID: 23092618
[TBL] [Abstract][Full Text] [Related]
4. In vitro metabolism, permeation, and brain availability of six major boswellic acids from Boswellia serrata gum resins.
Gerbeth K; Hüsch J; Fricker G; Werz O; Schubert-Zsilavecz M; Abdel-Tawab M
Fitoterapia; 2013 Jan; 84():99-106. PubMed ID: 23103296
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Pgp function by boswellic acids.
Weber CC; Reising K; Müller WE; Schubert-Zsilavecz M; Abdel-Tawab M
Planta Med; 2006 May; 72(6):507-13. PubMed ID: 16773534
[TBL] [Abstract][Full Text] [Related]
6. A single-dose, randomized, cross-over, two-way, open-label study for comparing the absorption of boswellic acids and its lecithin formulation.
Riva A; Morazzoni P; Artaria C; Allegrini P; Meins J; Savio D; Appendino G; Schubert-Zsilavecz M; Abdel-Tawab M
Phytomedicine; 2016 Nov; 23(12):1375-1382. PubMed ID: 27765357
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of solid lipid
Kulkarni PD; Damle ND; Hingorani L; Bhaskar VH; Ghante MR; Patil A; Gurjar M; Gota V
Drug Metab Pers Ther; 2021 Apr; 36(3):215-221. PubMed ID: 34412175
[TBL] [Abstract][Full Text] [Related]
8. A simple high-performance liquid chromatographic method for the estimation of boswellic acids from the market formulations containing Boswellia serrata extract.
Shah SA; Rathod IS; Suhagia BN; Pandya SS; Parmar VK
J Chromatogr Sci; 2008 Sep; 46(8):735-8. PubMed ID: 18796232
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of boswellic acids in vitro and in vivo.
Krüger P; Daneshfar R; Eckert GP; Klein J; Volmer DA; Bahr U; Müller WE; Karas M; Schubert-Zsilavecz M; Abdel-Tawab M
Drug Metab Dispos; 2008 Jun; 36(6):1135-42. PubMed ID: 18356270
[TBL] [Abstract][Full Text] [Related]
10. 11-Keto-α-Boswellic Acid, a Novel Triterpenoid from
Schmiech M; Ulrich J; Lang SJ; Büchele B; Paetz C; St-Gelais A; Syrovets T; Simmet T
Molecules; 2021 Jan; 26(2):. PubMed ID: 33445710
[TBL] [Abstract][Full Text] [Related]
11. Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data.
Abdel-Tawab M; Werz O; Schubert-Zsilavecz M
Clin Pharmacokinet; 2011 Jun; 50(6):349-69. PubMed ID: 21553931
[TBL] [Abstract][Full Text] [Related]
12. Complexation with phosphatidyl choline as a strategy for absorption enhancement of boswellic acid.
Sharma A; Gupta NK; Dixit VK
Drug Deliv; 2010 Nov; 17(8):587-95. PubMed ID: 20624027
[TBL] [Abstract][Full Text] [Related]
13. Biotransformation of 11-keto-β-boswellic acid by Cunninghamella blakesleana.
Wang Y; Sun Y; Wang C; Huo X; Liu P; Wang C; Zhang B; Zhan L; Zhang H; Deng S; Zhao Y; Ma X
Phytochemistry; 2013 Dec; 96():330-6. PubMed ID: 23962801
[TBL] [Abstract][Full Text] [Related]
14. Permeation of Boswellia extract in the Caco-2 model and possible interactions of its constituents KBA and AKBA with OATP1B3 and MRP2.
Krüger P; Kanzer J; Hummel J; Fricker G; Schubert-Zsilavecz M; Abdel-Tawab M
Eur J Pharm Sci; 2009 Feb; 36(2-3):275-84. PubMed ID: 19010411
[TBL] [Abstract][Full Text] [Related]
15. Investigating permeability related hurdles in oral delivery of 11-keto-β-boswellic acid.
Bagul P; Khomane KS; Bansal AK
Int J Pharm; 2014 Apr; 464(1-2):104-10. PubMed ID: 24463070
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Neuroprotection of Acetyl-11-Keto-β-Boswellic Acid (AKBA)-Loaded O-Carboxymethyl Chitosan Nanoparticles Through Antioxidant and Anti-Inflammatory Pathways.
Ding Y; Qiao Y; Wang M; Zhang H; Li L; Zhang Y; Ge J; Song Y; Li Y; Wen A
Mol Neurobiol; 2016 Aug; 53(6):3842-3853. PubMed ID: 26162321
[TBL] [Abstract][Full Text] [Related]
17. Development and optimization of boswellic acid-loaded proniosomal gel.
Mehta M; Dureja H; Garg M
Drug Deliv; 2016 Oct; 23(8):3072-3081. PubMed ID: 26953869
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of solid lipid
Kulkarni PD; Damle ND; Hingorani L; Bhaskar VH; Ghante MR; Patil A; Gurjar M; Gota V
Drug Metab Pers Ther; 2021 Apr; ():. PubMed ID: 33818023
[TBL] [Abstract][Full Text] [Related]
19. High-performance thin layer chromatographic analysis of anti-inflammatory triterpenoids from Boswellia serrata Roxb.
Krohn K; Rao MS; Raman NV; Khalilullah M
Phytochem Anal; 2001; 12(6):374-6. PubMed ID: 11793815
[TBL] [Abstract][Full Text] [Related]
20. Measurement of 3-acetyl-11-keto-beta-boswellic acid and 11-keto-beta-boswellic acid in Boswellia serrata Supplements Administered to Dogs.
Miscioscia E; Shmalberg J; Scott KC
BMC Vet Res; 2019 Aug; 15(1):270. PubMed ID: 31370899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
